China is now the second-largest pharmaceutical market in the world, and with a more harmonized and efficient clinical trial approval process, it is seeing a large increase in clinical trial activity – even during the COVID-19 pandemic. Ensuring that a clinical trial supply strategy is in line with current market requirements, and that a sponsor has considered all of their sourcing options, is essential to save time, resources and reduce costs. This webinar will provide two unique insights into this strategy and the key areas to focus on for success.
The featured speakers will address sponsors’ common concerns when establishing a clinical trial supply strategy in China, and provide solutions to problems that sponsors have experienced in the past, including:
- Have the regulatory requirements cost time and money and delayed the clinical trial plan?
- Have time, language, and cultural differences affected the efficiency of a project?
- Are there concerns about quality and reliability when initiating a trial in China?
- Is there uncertainty about how to assess sourcing options and determine what the best solution may be?
The challenges of running successful trials in China can be daunting, and getting comparator sourcing right from the start is essential. This webinar will focus on the key areas for success as participants hear both the pharmaceutical and service provider views on how to navigate the Chinese landscape effectively.
Join this webinar to find out more about overcoming these challenges, and learn how making the right strategic choices can have a positive impact on running clinical trials in China.
Chan Liu, Comparator Strategist Lead, Pfizer
Chan Liu, Comparator Strategist Lead, Pfizer, and Master in Pharmaceuticals, First Military Medical University-Nan Fang Hospital, is a leading expert in clinical supplies across the Asia region, incl. China. Chan is managing sourcing projects for both local, regional and global studies and is responsible for the planning and forecasting of comparator needs, coordination of regulatory reviews, confirmation of label requirements, etc. Furthermore, she has the responsibility for the management of all Pfizer vendors in the region.Message Presenter
Philip Gregory, Vice President, Asia Pacific, Clinical Trial Services, Inceptua
Philip is an experienced international pharmaceutical executive, having worked for large pharmaceutical companies, biotechnology firms and CROs. He has worked in the industry for 30 years in both International roles and country management. Philip has worked in Europe, USA, Australia, Japan and China where he has resided for the last 14 years.
Philip’s extensive knowledge of product development, clinical trials and international business will give some unique insights into the strategies that should be utilized for successful comparator sourcing in the Chinese market.Message Presenter
Who Should Attend?
This webinar will benefit those responsible for procurement and supply chain management in clinical trials, with relevant job titles including:
- Sourcing Manager
- Project Manager
- Pharmaceutical Executive – Global Clinical Trials
- Clinical Trials Manager/Coordinator
What You Will Learn
- Strategic options for comparator sourcing in China
- Critical factors to consider in designing a clinical trial program
- Considerations and hurdles for running trials in China, and how to overcome them
- Three key things to look for when choosing a sourcing partner for China
Inceptua is a specialized pharmaceutical company and a premium global service partner. We bring medicines to patients through clinical trial distribution services, pre-approval and unlicensed medicines access, and commercialization of specialty and rare disease products.